Labshake search
Citations for R&D Systems :
151 - 200 of 3878 citations for Ciprofloxacin Hcl 100 Ug Ml In Methanol 2 3 Carboxyl 13C3 99%; Quinoline 15N 98% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... IFNα (3×104 units/ml, R&D Systems, Minneapolis, MN), (3 ...
-
bioRxiv - Immunology 2023Quote: ... 30 ng/ml IL-3 (R&D Systems, 203-IL), 30 ng/ml TPO (PeproTech ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 days with 200 ng/mL FGF9 (R&D Systems), 1 μg/mL heparin (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... 10 ng/ml rhIL-3 (#203-IL, R&D Systems) and 10 ng/ml rhIL-6 (#206-IL ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (0.97 ng/ml; R&D Systems, 203-IL), CXCL12 (97.39 ng/ml) ...
-
bioRxiv - Immunology 2023Quote: ... IL-3 (5.3 ng/ml; R&D Systems, 203-IL), CXCL12 (9.7 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/mL NT-3 (R&D Systems, 267-N3), 10 ng/mL EGF ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), and Doxycycline Hydrochloride (1ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... Neurotrophin-3 (1ug/ml, 267-N3-025, R&D Systems), EdU (5-ethynyl-2’-deoxyuridine ...
-
bioRxiv - Developmental Biology 2021Quote: ... and then differentiated into day 2 definitive endoderm through the addition of CDM2 basal medium supplemented with Activin A (100 ng/mL; R&D Systems), LDN-193189 (250 nM ...
-
bioRxiv - Developmental Biology 2021Quote: ... cells were exposed to 1 µM EdU along with or withpout 2-100 ng/ml recombinant VEGFA (R&D Systems, 493-MV) for 8 hours before being fixed and stained by the Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2022Quote: CAR and BOXR1030 T cells were activated with immobilized recombinant GPC3 protein (0.3 ug/mL) (R&D Systems, Cat# 2119-GP-050) over a 6-day time course ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems). The medium was changed every 2 days ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems), SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Biophysics 2022Quote: ... The medium was supplemented with 10 ng/ml recombinant mouse IL-2 (rmIL-2) (402-ML, R&D systems) for long-term culture of mouse ILC2s.
-
bioRxiv - Microbiology 2021Quote: ... bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% FBS in the presence of FMS-like tyrosine kinase 3 ligand (Flt3L) (100 ng/ml, R&D Systems, Cat# 308-FK) for 7-9 days ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Genetics 2019Quote: ... 100 ng /ml activin A and 50 ng /ml WNT3a (R&D Systems). Day 2 ...
-
bioRxiv - Cell Biology 2021Quote: ... (v) 100 ng/ml Act A + 10 ng/ml FGF4 (R&D Systems) or (vi ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml EGF and 20ng/ml FGF-2 (R&D Systems). Cells were passaged regularly using Accutase (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2020Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA).
-
bioRxiv - Cell Biology 2021Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA). MCF7 ...
-
bioRxiv - Systems Biology 2021Quote: ... HGF 50 ng/ml; NT-3 10 ng/ml; PDGF-BB 10 ng/ml; GDNF 10 ng/ml; All from R&D systems). Ligand treatment was started at the time of tetracycline induction ...
-
bioRxiv - Cancer Biology 2022Quote: ... 2 μg/mL Fibulin-2 (Cat no. 9559-FB-050, R&D Systems) coated ...
-
bioRxiv - Immunology 2023Quote: ... and were cultured with 50U/ml hIL-2 (Th0) or 100U/ml hIL-2 and 5ng/ml murine TGFβ (R&D Systems, 7666-MB/CF) for 4-5 days.
-
bioRxiv - Immunology 2024Quote: ... the cells were incubated with IFNγ (100 ng/ml, R&D Systems 485-MI-100) and LPS (100 ng/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Microbiology 2023Quote: ... the cells were cultured for 3 d (days 0–3) using SFD medium supplemented with 10 μM Y-27632 and 100 ng/mL recombinant Activin A (R&D Systems, Cat# 338-AC-010). For anterior foregut endoderm induction (days 3–5) ...
-
bioRxiv - Cell Biology 2020Quote: ... recombinant human NOGGIN (100 ng/ml, R&D Systems), recombinant human EGF (50 ng/ml ...
-
bioRxiv - Developmental Biology 2020Quote: ... 100 ng/mL Noggin (R&D Systems, #6057-NG), 10 mM Y-27632 dyhydrochloride (Chemdea ...
-
bioRxiv - Developmental Biology 2021Quote: ... and/or 100 ng/ml ACTIVIN (R&D Systems). Fixed samples were analyzed by immunofluorescence 1 ...
-
bioRxiv - Genetics 2019Quote: ... and Activin A (100 ng/ml; R&D Systems) for 24 hours and subsequently in RPMI medium containing Activin A (100 ng/ml ...
-
bioRxiv - Genetics 2019Quote: ... and Activin A (100 ng/ml; R&D Systems) for 24h.
-
bioRxiv - Immunology 2019Quote: ... and IL-6 (100 pg/ml; R&D Systems).
-
bioRxiv - Immunology 2022Quote: ... anti-TLR2 mAb (100 μg/ml, R&D system), or a mixture of anti-CLEC5A mAb and anti-TLR2 mAb for 30 min at room temperature before incubation with SARS-CoV-2 ...
-
bioRxiv - Biochemistry 2022Quote: ... 100 ng ml-1 CXCL12-α (R&D Systems) and/or 100 nM VUF11207 (Cayman Chemical ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 ng/ml Activin A (R&D Systems) for 3 days ...
-
bioRxiv - Immunology 2022Quote: ... 100 ng/ml recombinant murine CXCL12 (R&D Systems) was added to the cultures ...
-
bioRxiv - Cell Biology 2022Quote: ... and 100 ng/ml murine EGF (R&D Systems). 2500 cells were then embedded in 5ul drop of Matrigel/medium in 60/40 ratio ...
-
bioRxiv - Cancer Biology 2020Quote: ... 100 ng/mL IGF1 (291-G1, R&D Systems), 25 ng/mL EGF (E9644 ...
-
bioRxiv - Microbiology 2021Quote: ... and 100 ng/ml human Activin (R&D Systems), in a 5% CO2/5% O2 atmosphere at 37 °C for 72-76 h ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/mL ActivinA (R&D Systems #338-AC), and 1:60 diluted growth-factor-reduced Matrigel ...
-
bioRxiv - Cell Biology 2022Quote: ... and 100 ng/ml murine EGF (R&D Systems) and mixed 1:1 with Matrigel (Corning) ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100 ng/ml rhFGF10 (R&D Systems, # 345-FG), 100 ng/ml Heparin Salt (Millipore Sigma ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100 ng/ml rhFGF10 (R&D Systems, # 345-FG), and 10 μM Y-27632 (Tocris ...
-
bioRxiv - Developmental Biology 2022Quote: ... 100 ng/ml rhFGF2 (R&D Systems, #233-FB), 100 ng/ml rhFGF10 (R&D Systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... Noggin (500ng/ml; R&D Systems; 6057-NG-100), IWP2 (Stemgent ...
-
bioRxiv - Developmental Biology 2023Quote: ... Noggin (250ng/ml; R&D Systems; 6057-NG-100), IWP2 (Stemgent ...